NICE LTD - SPON ADR (NICE) Fundamental Analysis & Valuation

NASDAQ:NICE • US6536561086

Current stock price

117.39 USD
-0.97 (-0.82%)
At close:
117.39 USD
0 (0%)
After Hours:

This NICE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. NICE Profitability Analysis

1.1 Basic Checks

  • In the past year NICE was profitable.
  • NICE had a positive operating cash flow in the past year.
  • NICE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years NICE had a positive operating cash flow.
NICE Yearly Net Income VS EBIT VS OCF VS FCFNICE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

1.2 Ratios

  • NICE's Return On Assets of 11.99% is amongst the best of the industry. NICE outperforms 88.45% of its industry peers.
  • The Return On Equity of NICE (15.79%) is better than 83.39% of its industry peers.
  • NICE has a Return On Invested Capital of 12.43%. This is amongst the best in the industry. NICE outperforms 89.53% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NICE is in line with the industry average of 10.89%.
  • The last Return On Invested Capital (12.43%) for NICE is above the 3 year average (10.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.99%
ROE 15.79%
ROIC 12.43%
ROA(3y)8.95%
ROA(5y)7.31%
ROE(3y)12.7%
ROE(5y)10.78%
ROIC(3y)10.98%
ROIC(5y)9.27%
NICE Yearly ROA, ROE, ROICNICE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • NICE's Profit Margin of 20.78% is amongst the best of the industry. NICE outperforms 87.00% of its industry peers.
  • In the last couple of years the Profit Margin of NICE has grown nicely.
  • The Operating Margin of NICE (22.23%) is better than 89.53% of its industry peers.
  • In the last couple of years the Operating Margin of NICE has grown nicely.
  • NICE has a Gross Margin of 66.41%. This is comparable to the rest of the industry: NICE outperforms 45.85% of its industry peers.
  • NICE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.23%
PM (TTM) 20.78%
GM 66.41%
OM growth 3Y13.1%
OM growth 5Y8.49%
PM growth 3Y19.58%
PM growth 5Y11.73%
GM growth 3Y-1.1%
GM growth 5Y0.15%
NICE Yearly Profit, Operating, Gross MarginsNICE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. NICE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NICE is still creating some value.
  • The number of shares outstanding for NICE has been reduced compared to 1 year ago.
  • The number of shares outstanding for NICE has been reduced compared to 5 years ago.
  • There is no outstanding debt for NICE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NICE Yearly Shares OutstandingNICE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
NICE Yearly Total Debt VS Total AssetsNICE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • There is no outstanding debt for NICE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.41
WACC8.79%
NICE Yearly LT Debt VS Equity VS FCFNICE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • NICE has a Current Ratio of 1.55. This is a normal value and indicates that NICE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.55, NICE is in line with its industry, outperforming 46.57% of the companies in the same industry.
  • A Quick Ratio of 1.55 indicates that NICE should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.55, NICE perfoms like the industry average, outperforming 47.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.55
NICE Yearly Current Assets VS Current LiabilitesNICE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NICE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.61% over the past year.
  • The Earnings Per Share has been growing by 16.51% on average over the past years. This is quite good.
  • NICE shows a small growth in Revenue. In the last year, the Revenue has grown by 7.68%.
  • Measured over the past years, NICE shows a quite strong growth in Revenue. The Revenue has been growing by 12.31% on average per year.
EPS 1Y (TTM)10.61%
EPS 3Y17.3%
EPS 5Y16.51%
EPS Q2Q%7.28%
Revenue 1Y (TTM)7.68%
Revenue growth 3Y10.53%
Revenue growth 5Y12.31%
Sales Q2Q%8.99%

3.2 Future

  • Based on estimates for the next years, NICE will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.06% on average per year.
  • The Revenue is expected to grow by 10.35% on average over the next years. This is quite good.
EPS Next Y-9%
EPS Next 2Y1.46%
EPS Next 3Y8.06%
EPS Next 5YN/A
Revenue Next Year8.31%
Revenue Next 2Y9%
Revenue Next 3Y10.35%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NICE Yearly Revenue VS EstimatesNICE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
NICE Yearly EPS VS EstimatesNICE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

8

4. NICE Valuation Analysis

4.1 Price/Earnings Ratio

  • NICE is valuated reasonably with a Price/Earnings ratio of 9.41.
  • 89.53% of the companies in the same industry are more expensive than NICE, based on the Price/Earnings ratio.
  • NICE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.70.
  • With a Price/Forward Earnings ratio of 10.35, the valuation of NICE can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, NICE is valued cheaper than 83.75% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, NICE is valued rather cheaply.
Industry RankSector Rank
PE 9.41
Fwd PE 10.35
NICE Price Earnings VS Forward Price EarningsNICE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 92.06% of the companies in the same industry are more expensive than NICE, based on the Enterprise Value to EBITDA ratio.
  • NICE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NICE is cheaper than 86.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.64
EV/EBITDA 7.95
NICE Per share dataNICE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The excellent profitability rating of NICE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.57
EPS Next 2Y1.46%
EPS Next 3Y8.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NICE Dividend Analysis

5.1 Amount

  • NICE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NICE Fundamentals: All Metrics, Ratios and Statistics

NICE LTD - SPON ADR

NASDAQ:NICE (3/13/2026, 8:00:02 PM)

After market: 117.39 0 (0%)

117.39

-0.97 (-0.82%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-19
Earnings (Next)05-13
Inst Owners12.68%
Inst Owner Change-10.51%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.25B
Revenue(TTM)2.95B
Net Income(TTM)612.10M
Analysts77.5
Price Target186.37 (58.76%)
Short Float %5.63%
Short Ratio3.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.56%
Min EPS beat(2)-1.87%
Max EPS beat(2)-1.24%
EPS beat(4)0
Avg EPS beat(4)-1.42%
Min EPS beat(4)-1.87%
Max EPS beat(4)-1.17%
EPS beat(8)3
Avg EPS beat(8)0.38%
EPS beat(12)7
Avg EPS beat(12)0.88%
EPS beat(16)11
Avg EPS beat(16)1.32%
Revenue beat(2)0
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-1.48%
Max Revenue beat(2)-1.06%
Revenue beat(4)0
Avg Revenue beat(4)-1.16%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.14%
Revenue beat(8)0
Avg Revenue beat(8)-1.29%
Revenue beat(12)0
Avg Revenue beat(12)-1.21%
Revenue beat(16)1
Avg Revenue beat(16)-1.06%
PT rev (1m)-9.87%
PT rev (3m)-9.78%
EPS NQ rev (1m)-4.39%
EPS NQ rev (3m)-6.09%
EPS NY rev (1m)-3.51%
EPS NY rev (3m)-4.94%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)0.22%
Valuation
Industry RankSector Rank
PE 9.41
Fwd PE 10.35
P/S 2.46
P/FCF 11.64
P/OCF 10.11
P/B 1.87
P/tB 8.54
EV/EBITDA 7.95
EPS(TTM)12.47
EY10.62%
EPS(NY)11.34
Fwd EY9.66%
FCF(TTM)10.09
FCFY8.59%
OCF(TTM)11.61
OCFY9.89%
SpS47.71
BVpS62.79
TBVpS13.74
PEG (NY)N/A
PEG (5Y)0.57
Graham Number132.73
Profitability
Industry RankSector Rank
ROA 11.99%
ROE 15.79%
ROCE 15.52%
ROIC 12.43%
ROICexc 13.79%
ROICexgc 67.83%
OM 22.23%
PM (TTM) 20.78%
GM 66.41%
FCFM 21.14%
ROA(3y)8.95%
ROA(5y)7.31%
ROE(3y)12.7%
ROE(5y)10.78%
ROIC(3y)10.98%
ROIC(5y)9.27%
ROICexc(3y)15.89%
ROICexc(5y)14.15%
ROICexgc(3y)171.95%
ROICexgc(5y)157.55%
ROCE(3y)13.71%
ROCE(5y)11.58%
ROICexgc growth 3Y-7.32%
ROICexgc growth 5YN/A
ROICexc growth 3Y3.25%
ROICexc growth 5Y4.04%
OM growth 3Y13.1%
OM growth 5Y8.49%
PM growth 3Y19.58%
PM growth 5Y11.73%
GM growth 3Y-1.1%
GM growth 5Y0.15%
F-Score7
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 47.1%
Cap/Sales 3.18%
Interest Coverage 2923.37
Cash Conversion 83.92%
Profit Quality 101.75%
Current Ratio 1.55
Quick Ratio 1.55
Altman-Z N/A
F-Score7
WACC8.79%
ROIC/WACC1.41
Cap/Depr(3y)48.69%
Cap/Depr(5y)45.79%
Cap/Sales(3y)3.46%
Cap/Sales(5y)3.52%
Profit Quality(3y)136.78%
Profit Quality(5y)151.62%
High Growth Momentum
Growth
EPS 1Y (TTM)10.61%
EPS 3Y17.3%
EPS 5Y16.51%
EPS Q2Q%7.28%
EPS Next Y-9%
EPS Next 2Y1.46%
EPS Next 3Y8.06%
EPS Next 5YN/A
Revenue 1Y (TTM)7.68%
Revenue growth 3Y10.53%
Revenue growth 5Y12.31%
Sales Q2Q%8.99%
Revenue Next Year8.31%
Revenue Next 2Y9%
Revenue Next 3Y10.35%
Revenue Next 5YN/A
EBIT growth 1Y19.44%
EBIT growth 3Y25.01%
EBIT growth 5Y21.85%
EBIT Next Year5.3%
EBIT Next 3Y10.36%
EBIT Next 5YN/A
FCF growth 1Y-15.02%
FCF growth 3Y16.11%
FCF growth 5Y8.35%
OCF growth 1Y-13.94%
OCF growth 3Y14.31%
OCF growth 5Y8.33%

NICE LTD - SPON ADR / NICE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NICE LTD - SPON ADR (NICE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to NICE.


Can you provide the valuation status for NICE LTD - SPON ADR?

ChartMill assigns a valuation rating of 8 / 10 to NICE LTD - SPON ADR (NICE). This can be considered as Undervalued.


Can you provide the profitability details for NICE LTD - SPON ADR?

NICE LTD - SPON ADR (NICE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for NICE stock?

The Price/Earnings (PE) ratio for NICE LTD - SPON ADR (NICE) is 9.41 and the Price/Book (PB) ratio is 1.87.


What is the financial health of NICE LTD - SPON ADR (NICE) stock?

The financial health rating of NICE LTD - SPON ADR (NICE) is 6 / 10.